Month: April 2024

Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024

Written by Customer Service on April 25, 2024. Posted in Earnings Releases And Operating Results.

– Enrollment continued on target in EMERALD-2 Phase 2b trial of MORF-057 in ulcerative colitis- -Appointed Dr. Simon Cooper as Chief Medical Officer- -Anticipate dosing first patient in GARNET Phase 2 study of MORF-057 in patients with moderate-to-severe Crohn’s disease in second quarter- -Ended first quarter with $658.8 million in cash, cash equivalents, and marketable securities; cash runway into second half of 2027- WALTHAM, Mass., April 25, 2024 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today reported corporate highlights and financial results for the first quarter 2024. “Morphic continues to execute our strategy with the EMERALD-2 phase 2b study in ulcerative colitis (UC) recruiting...

Kirby Corporation Announces 2024 First Quarter Results

Written by Customer Service on April 25, 2024. Posted in Earnings Releases And Operating Results.

First quarter 2024 earnings per share of $1.19Inland marine experienced strong market conditions with a sequential increase in spot market prices and high-teens operating margins despite a sequential increase in delay daysCoastal operating margins improved to high single to low double-digit rangeBreaking out power generation at KDS as its significance continues to grow, constituting 41% of KDS revenues Kirby repurchased 498,505 shares at an average price of $83.82 for $41.8 million in the 2024 first quarterAcquired 13 barges, including three specialty barges, and two high horsepower boats from undisclosed sellerQuarterly earnings expected to strengthen as the year progresses Appoints Christian O’Neil as President and Chief Operating Officer effective April 26, 2024HOUSTON, April 25, 2024 (GLOBE NEWSWIRE) — Kirby...

Plato Gold Reports on 2023 Year-End Results

Written by Customer Service on April 25, 2024. Posted in Public Companies.

Toronto, ON, April 25, 2024 (GLOBE NEWSWIRE) — Plato Gold Corp. (TSX-V: PGC) (OTCQB: NIOVF) (Frankfurt: 4Y7 or WKN: A0M2QX) (“Plato” or the “Company”) an exploration company with a portfolio of properties in Northern Ontario and Santa Cruz, Argentina is pleased to report the twelve and three months financial results for fiscal 2023 and 2022, as summarized below: Year Ended Three Months Ended (Audited) (Unaudited) December 31, December 31, December 31, December 31, 2023 2022 2023 2022 Income $ 2,052 $ 2,222 $ 512 $ 518 Net Income (Loss) and Comprehensive Income (Loss) $ (347,405 ) $ (239,259 ) $ (183,650 ) $ (30,647 ) Loss per common share – basic and diluted – – – – Weighted...

Orezone Intersects 18.41 g/t Gold Over 8.00m and 22.17 g/t Gold Over 4.00m in Ongoing Exploration

Written by Customer Service on April 25, 2024. Posted in Public Companies.

VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) — Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (the “Company” or “Orezone”) is pleased to provide drill results from its Bomboré Gold Mine located in central Burkina Faso. The results are part of Orezone’s ongoing infill and advanced grade control program which was designed to further delineate multiple high-grade structures within the P8P9 Zone. All reported intercepts are in shallow oxides and are located within 1.5km of the Bomboré processing facility. Drilling Highlights:18.41 g/t Au over 8.00m from 12.00m in hole BBC5771 11.92 g/t Au over 4.00m from 64.00m in hole BBC5786 4.27 g/t Au over 7.00m from 42.00m in hole BBC5826 2.63 g/t Au over 12.00m from 19.00m in hole BBC5828 17.59 g/t Au over 5.00m from 30.00m in hole BBC5829 22.17 g/t Au over 4.00m from 26.00m...

XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)

Written by Customer Service on April 25, 2024. Posted in Public Companies.

XOMA is entitled to a mid-single digit royalty on global OJEMDA™ sales First and only FDA-approved type II RAF inhibitor for patients with relapsed or refractory pLGG harboring a BRAF fusion or rearrangement, or BRAF V600 mutation EMERYVILLE, Calif., April 25, 2024 (GLOBE NEWSWIRE) — XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today it has earned a $9 million milestone related to the U.S. Food and Drug Administration’s (FDA) approval of Day One Biopharmaceuticals’ New Drug Application (NDA) for OJEMDA™ (tovorafenib) for the treatment of patients 6 months of age and older with relapsed or refractory pediatric low-grade glioma (LGG) harboring a BRAF fusion or rearrangement, or BRAF V600 mutation. “This is an important milestone for XOMA and our royalty portfolio, but more importantly,...

Kura Oncology to Report First Quarter 2024 Financial Results

Written by Customer Service on April 25, 2024. Posted in Public Companies.

SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that it will report first quarter 2024 financial results after the close of U.S. financial markets on Thursday, May 2, 2024. Kura’s management will host a webcast and conference call at 4:30 p.m. ET / 1:30 p.m. PT that day to discuss the financial results and provide a corporate update. The live call may be accessed by dialing (888) 886-7786 for domestic callers and (416) 764-8658 for international callers. A live webcast and archived replay of the event will be available here or online from the investor relations section of the company website at www.kuraoncology.com. About Kura Oncology Kura Oncology is...

Jushi Holdings Inc. to Report First Quarter 2024 Financial Results on May 9, 2024

Written by Customer Service on April 25, 2024. Posted in Public Companies.

BOCA RATON, Fla., April 25, 2024 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the first quarter ended March 31, 2024, after the market closes on Thursday, May 9, 2024. Management will host a conference call and audio webcast on Thursday, May 9, 2024, at 4:30 p.m. ET to discuss the Company’s financial results.Event: First Quarter 2024 Financial Results Conference CallDate: Thursday, May 9, 2024Time: 4:30 p.m. Eastern TimeLive Call: 1-877-407-0792 (U.S. & Canada Toll-Free)Conference ID 13745557Webcast: Register For interested individuals unable to join the conference call, a webcast of the call will be available for one month following...

FTI Consulting Reports Record First Quarter 2024 Financial Results

Written by Customer Service on April 25, 2024. Posted in Public Companies.

First Quarter 2024 Revenues of $928.6 Million, Up 15% Compared to $806.7 Million in Prior Year Quarter First Quarter 2024 EPS of $2.23, Up 66% Compared to $1.34 in Prior Year QuarterWASHINGTON, April 25, 2024 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today released financial results for the first quarter ended March 31, 2024. First quarter 2024 revenues of $928.6 million increased $121.8 million, or 15.1%, compared to revenues of $806.7 million in the prior year quarter. The increase in revenues was primarily due to higher demand across all business segments. Net income of $80.0 million compared to $47.5 million in the prior year quarter. The increase in net income was primarily due to higher revenues, a lower effective tax rate and lower FX remeasurement losses compared to the prior year quarter, which was partially...

Altisource Announces First Quarter 2024 Financial Results

Written by Customer Service on April 25, 2024. Posted in Earnings Releases And Operating Results.

LUXEMBOURG, April 25, 2024 (GLOBE NEWSWIRE) — Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today reported financial results for the first quarter 2024. “I am very pleased with our first quarter performance. We generated $4.6 million of Adjusted EBITDA(1), marking our best quarterly performance since the third quarter of 2020, on $36.9 million of service revenue. We are winning meaningful new business and ramping 2023 sales wins on a lower cost base. In our Servicer and Real Estate segment, we are winning market share. In our Origination segment, we are increasing adoption of our solutions that help originators save money,” said Chairman and Chief Executive Officer William B. Shepro. Mr. Shepro further commented,...

Nasdaq Announces 9% Increase in Quarterly Dividend to $0.24 Per Share

Written by Customer Service on April 25, 2024. Posted in Dividend Reports And Estimates.

NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) — The Board of Directors of Nasdaq, Inc. (Nasdaq: NDAQ) has declared a regular quarterly dividend of $0.24 per share on the company’s outstanding common stock, a 9% increase from the previous quarter. The dividend is payable on June 28, 2024 to shareholders of record at the close of business on June 14, 2024. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to approval by the Board of Directors. About Nasdaq Nasdaq (Nasdaq: NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that improve the liquidity,...

Month: April 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals